ST
PCRX icon

Spot Trading’s Pacira BioSciences PCRX Stock Holding History

Spot Trading’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,865
Closed -$152K – 3694
2016
Q1 		$152K Buy
2,865
+991
+53% +$58K ﹤0.01% 2371
2015
Q4 		$144K Buy
+1,874
New +$106K ﹤0.01% 2647

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Spot Trading's PCRX Position: Q2 2016 in Review

Spot Trading sold out of Pacira BioSciences (PCRX) in Q2 2016, closing a stake of 2,865 shares — an estimated $152K sold.

Spot Trading first reported a position in PCRX in Q4 2015 and held it in 2 quarters. The position peaked at $152K in Q1 2016. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2016.

  • Spot Trading reported no remaining Pacira BioSciences position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 2,865 Pacira BioSciences shares in Q2 2016, an estimated $152K.
  • Spot Trading first reported a position in Pacira BioSciences in Q4 2015 and held it in 2 quarters.
  • Spot Trading's Pacira BioSciences position peaked at $152K in Q1 2016.
  • 183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.